CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	6 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Cash flows from operating activities:
Net income (loss)	$ (30,000)	$ 383,000
Adjustments to reconcile net income (loss) to net cash:
Stock compensation expense	190,000	230,000
Foreign exchange loss (gain)	8,000	(33,000)
Depreciation and amortization	693,000	610,000
Deferred income taxes	136,000	(710,000)
Non-cash R&D services	0	200,000
Other	14,000	50,000
Other changes in assets and liabilities:
Accounts receivable, net	120,000	(811,000)
Unbilled receivables	(1,299,000)	472,000
Contract assets	(37,000)	0
Inventories	(437,000)	(279,000)
Prepaid expenses and other assets	(180,000)	189,000
Accounts payable	(137,000)	(646,000)
Accrued expenses and other liabilities	(335,000)	123,000
Contract liabilities	(228,000)	(3,000)
Net cash from operating activities	(1,522,000)	(225,000)
Cash flows from investing activities:
Purchases of property, plant and equipment	(561,000)	(1,005,000)
Purchase of intangibles	0	(45,000)
Net cash from investing activities	(561,000)	(1,050,000)
Cash flows from financing activities:
Proceeds from issuance of common stock	10,000	8,000
Principal payments on capital leases	(21,000)	(50,000)
Proceeds from (payments of) equipment line of credit, net	484,000	281,000
Proceeds from (payments of) bank and subordinated debt, net	(360,000)	(277,000)
Net cash from financing activities	113,000	(38,000)
Effect of exchange rates on cash and cash equivalents	(7,000)	28,000
Net change in cash and cash equivalents	(1,977,000)	(1,285,000)
Cash and cash equivalents, beginning	2,327,000	2,415,000
Cash and cash equivalents, ending	350,000	1,130,000
Supplemental disclosures of cash flow information:
Cash paid during the year for: Interest	83,000	77,000
Cash paid during the year for: Tax payments (refunds)	(5,000)	5,000
Non cash activities:
Xcede stock surrender of Series A Preferred (in shares)	$ 18,000	$ 0